LCRF, UALC merge to fight deadliest cancer
The required regulatory documents for the merger were approved by the New York State Attorney General on May 20, 2015. The combined entity, which will carry on the
The required regulatory documents for the merger were approved by the New York State Attorney General on May 20, 2015. The combined entity, which will carry on the
The acquisition brings to Biota AP611074, a patented, direct-acting antiviral in clinical development for the treatment of condyloma, or anogenital warts, as well as the orphan disease recurrent
The open-label, single-arm, Phase 2 study is a thorough PK/PD assessment designed to: (1) measure the effects of CPX-351 on cardiac repolarization following the first induction cycle of
The company’s latest report* states that the global pharmaceutical industry is currently being confronted with intensified obstacles along the path to new product commercialization, with pricing and reimbursement
The Boston/Cambridge, Massachusetts area, and Zurich, Switzerland will serve as VBU’s global hubs for the vaccine business outside of Japan. VBU will maintain regional hubs in Singapore and
Trailing twelve-month sales for the product are $30 million, according to IMS, with three current competitors. ANI expects to begin shipping to its customers shortly. Arthur S. Przybyl,
Key components of the agreement include:– A new company, Kanyos Bio, Inc. ("Kanyos", location: Cambridge, MA), has been created to develop clinical candidates in the two selected indications,
The decision followed the Positive Opinion adopted by the Committee for Medicinal Products for Human Use (CHMP) on March 26 2015 and is applicable to all 28 European
Anthim is a candidate for future acquisition into the Strategic National Stockpile, the U.S. government’s repository of critical medical supplies for biowarfare preparedness. Anthim has been developed under
Vitesse is a unique collaboration model initiated by Baxter Ventures to focus on the development of antibody and protein-based therapeutics in the areas of immunology, hematology, and oncology.